This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. We look for similar customer-oriented ethos and patient-centric mindsets in our partnerships,” said Kim Kushner, Chief Business Officer, SSI Strategy. Learn more at koneksahealth.com.
While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions. This is down from 6.5x
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients.
The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Natural-Based Therapies: Honey: Honey has antimicrobial properties and can promote wound healing.
“In only seven years, Health+Commerce has built a highly respected organization providing strategic programs that reach clinician, investor and consumer audiences in the multibillion-dollar medtech, biotech and digital health sectors. We look forward to supporting the agency as it continues on its growth trajectory.”
As our ability to utilize data to demonstrate positive clinical outcomes continues to be enhanced through technology, healthcare and biotech companies are under increasing pressure to demonstrate positive clinical outcomes and patient benefits from these investments.
So much so that, according to Gartner Prediction, by 2025, 25% of Healthcare Delivery Organizations will include formalized digital twin initiatives within their digital transformation strategy as it enables the development of digital representations of real-world assets.
Keech Combe Shetty, granddaughter of Ivan and Co-CEO of Combe, bolstered the importance of women’s leadership in the health care industry as both a role model and supporter. Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/life science, and hospitals.
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin has demonstrated strong leadership to his teams and customers alike.” Contacts Rob Wilson – Vice President of Marketing Strategy rob.wilson@vivosense.com Tel: +1 858-876-8486
At Solas, we invest in game-changing healthcare innovation and strong leadership teams committed to creating meaningful patient impact,” said Dr. David Adair, Managing Director of Solas BioVentures. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.
Global marketing strategy and marketing consulting firm Simon-Kucher & Partners surveyed more than 120 managers from the pharma and medtech industries in August and September of this year to […].
From digital health to biotech, from Pre-Seed to Series B, and from first-time founders to serial entrepreneurs, this cohort is indeed eclectic. . “The 2024 companies represent the very best of mental health innovation and we are excited to welcome them into the One Mind Accelerator,” said Brandon Staglin, President of One Mind.
Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion manages well over EUR 2.3
This commitment has resulted in a national digital health strategy and the creation of the Digital Health & Care Innovation Centre (DHI), which supports collaboration and innovation in the sector. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Best Mobile Innovation for Health and BioTech c. Centre for Information Policy Leadership. Director of Product Strategy. Date & Time. Monday, 25 Feb. 10:00 – 10:30. Description. Fourth Industrial Revolution a. Best Mobile Innovation for Enterprise b. Best Mobile Innovation for Education. Partner Programmes. The Future.
“BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.
Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content